Chronic mild stress paradigm as a rat model of depression: facts, artifacts, and future perspectives
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Rationale: The chronic mild stress (CMS) paradigm was first described almost 40 years ago and has become a widely used model in the search for antidepressant drugs for major depression disorder (MDD). It has resulted in the publication of almost 1700 studies in rats alone. Under the original CMS procedure, the expression of an anhedonic response, a key symptom of depression, was seen as an essential feature of both the model and a depressive state. The prolonged exposure of rodents to unpredictable/uncontrollable mild stressors leads to a reduction in the intake of palatable liquids, behavioral despair, locomotor inhibition, anxiety-like changes, and vegetative (somatic) abnormalities. Many of the CMS studies do not report these patterns of behaviors, and they often fail to include consistent molecular, neuroanatomical, and physiological phenotypes of CMS-exposed animals. Objectives: To critically review the CMS studies in rats so that conceptual and methodological flaws can be avoided in future studies. Results: Analysis of the literature supports the validity of the CMS model and its impact on the field. However, further improvements could be achieved by (i) the stratification of animals into ‘resilient’ and ‘susceptible’ cohorts within the CMS animals, (ii) the use of more refined protocols in the sucrose test to mitigate physiological and physical artifacts, and (iii) the systematic evaluation of the non-specific effects of CMS and implementation of appropriate adjustments within the behavioral tests. Conclusions: We propose methodological revisions and the use of more advanced behavioral tests to refine the rat CMS paradigm, which offers a valuable tool for developing new antidepressant medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A typology of reviews: an analysis of 14 review types and associated methodologies
Grant, M. J., & Booth, A. (2009) · Health Information & Libraries Journal · doi:10.1111/j.1471-1842.2009.00848.x · Cited by 10,817
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.01.011 · Cited by 2,779
The Epidemiology of Depression Across Cultures
Kessler, R. C., & Bromet, E. J. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114409 · Cited by 2,657
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 4×
“2012), social defeat (Meerlo et al. 1999; Von Frijtag et al. 2000; Krishnan et al. 2007; Cline et al. 2015; Riga et al. 2015), exposure to ultrasonic sounds with negative emotional valence (Morozova et al.”
BackgroundMethodInfluentialStephan, F. K., & Zucker, I. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1583 · Cited by 2,039
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737 · cited 1×
“…Kong 5 Institute of General Pathology and Pathophysiology, RAS, Moscow, Russia 6 P.K. Anokhin Research Institute of Normal Physiology, Moscow, Russia 7 Department of Pharmacology, Oxford University, Oxford, UK experience MDD over the course of a lifetime (Hasin et al. 2018; Gauthier et al. 2019).”
BackgroundWillner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605 · cited 10×
“…in MDD, these and other locomotor changes in laboratory rodents can be observed in stressed rats with no signs of hedonic deficit (for a review see:Willner 2005; Slattary and Cryan 2014; Belovicova et al. 2017; Harro 2019) and therefore cannot be directly attributed to clinically relevant…”
BackgroundMethodInfluentialAssessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 5×
“As a consequence of the issues relating to the reproducibility and inconsistencies of stressinduced anhedonia, as measured by sucrose preference, the implementation and interpretation of the data from CMS models in relation to MDD research has proved problematic (for a review, see: Nestler et al. 2002; Cryan et al. 20…”
BackgroundMethodInfluentialPsychobiology and molecular genetics of resilience
Feder, A., Nestler, E. J., & Charney, D. S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2649 · Cited by 1,272 · cited 2×
“Studies employing this method have revealed new important biomarkers of depression and potential therapeutic targets that can aid in the development of personalized therapeutic regimes (Mill and Petronis 2007; Alter et al. 2008; Feder et al. 2009; Demin et al. 2019).”
BackgroundMethodChronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160 · cited 5×
“Secondly, the CMS model is associated with the development of anhedonia, a reduction of sensitivity to a reward, which was established as the primary criterion of a depressive-like state in animals (Willner et al. 1987; Willner 1992).”
BackgroundMethodInfluentialLi, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082
The chronic mild stress (CMS) model of depression: History, evaluation and usage
Willner, P. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.002 · Cited by 959
IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862 · cited 1×
“For examples of the variability reported in these tests, Banasr et al. (2007, 2008) and Koo and Duman (2008) (Wang, 2008 #55) reported 33–35% sucrose preference in stressed animals and 70-75% sucrose preference in control animals, whereas Song et al. (2018), Banasr et al. (2010), and Bessa et al.…”
BackgroundThe COVID-19 pandemic: the ‘black swan’for mental health care and a turning point for e-health
Wind, T. R., Rijkeboer, M., Andersson, G., & Riper, H. (2020) · Internet Interventions · doi:10.1016/j.invent.2020.100317 · Cited by 782
The Forced Swim Test as a Model of Depressive-like Behavior
Yankelevitch-Yahav, R., Franko, M., Huly, A., & Doron, R. (2015) · Journal of Visualized Experiments · doi:10.3791/52587 · Cited by 754
Antoniuk, S., Bijata, M., Ponimaskin, E., & Wlodarczyk, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.002 · Cited by 750
Kreisel, T., Frank, M. G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M. V., Maier, S. F., & Yirmiya, R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.155 · Cited by 663
Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598
Assessing anhedonia in depression: potentials and pitfalls
Rizvi, S. J., Pizzagalli, D. A., Sproule, B. A., & Kennedy, S. H. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.004 · Cited by 571 · cited 2×
“MDD is also often associated with psychomotor inhibition, vegetative (somatic) symptoms, cognitive abnormalities, changes in appetite and body weight (Kessler et al. 2005; Kessler and Bromet 2013; Rizvi et al. 2016), as well as sleep disturbances (Baglioni et al. 2011).”
BackgroundStress, depression, and anhedonia: caveats concerning animal models
Anisman, H., & Matheson, K. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.007 · Cited by 569
Papp, M., Willner, P., & Muscat, R. (1991) · Psychopharmacology · doi:10.1007/bf02244188 · Cited by 542 · cited 1×
“Additionally, CMS-induced depression-like changes can be alleviated with antidepressant treatments, suggesting pharmacological sensitivity of the CMS-induced pathology (Papp et al. 1994, 1996, 2003, 2016; Cryan et al. 2002; McAthur and Borsini 2006; Antoniuk et al. 2019).”
BackgroundThe Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior
Commons, K. G., Cholanians, A. B., Babb, J. A., & Ehlinger, D. G. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00042 · Cited by 525 · cited 1×
“However, we accept that the use of ‘despair behavior’ might be considered by some to be problematic because of its anthropomorphic connotations and we also accept that a degree of caution is warranted when using this term (Commons et al. 2017; Molendijk and de Kloet 2019).”
BackgroundAnimal model of depression: Pharmacological sensitivity of a hedonic deficit
Katz, R. J. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90053-3 · Cited by 480
Banasr, M., Chowdhury, G. M. I., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., & Sanacora, G. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.106 · Cited by 458
Leptin: A potential novel antidepressant
Lu, X.-Y., Kim, C. S., Frazer, A., & Zhang, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508901103 · Cited by 446
Wang, Y.-L., Han, Q.-Q., Gong, W.-Q., Pan, D.-H., Wang, L.-Z., Hu, W., Yang, M., Li, B., Yu, J., & Liu, Q. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1054-3 · Cited by 438
Bondi, C. O., Rodriguez, G., Gould, G. G., Frazer, A., & Morilak, D. A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301410 · Cited by 398
Hill, M. N., Patel, S., Carrier, E. J., Rademacher, D. J., Ormerod, B. K., Hillard, C. J., & Gorzalka, B. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300601 · Cited by 363
Efficacy and effectiveness of antidepressants: current status of research
Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000318293 · Cited by 347 · cited 2×
“Despite a variety of therapeutic regimens available for depression, many of them appear to be effective in only about a half of patients, and up to 35% of MDD cases remain refractory to treatment (Munos 2009; Pigott et al. 2010; Insel and Sahakian 2012; Moeler 2017; Dubovsky 2018; Safer and Zito 2019).”
BackgroundYue, N., Huang, H., Zhu, X., Han, Q., Wang, Y., Li, B., Liu, Q., Wu, G., Zhang, Y., & Yu, J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0865-y · Cited by 334
Heine, V. M., Maslam, S., Zareno, J., Joëls, M., & Lucassen, P. J. (2004) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.03100.x · Cited by 317
Resilience to Chronic Stress Is Mediated by Hippocampal Brain-Derived Neurotrophic Factor
Taliaz, D., Loya, A., Gersner, R., Haramati, S., Chen, A., & Zangen, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5725-10.2011 · Cited by 311 · cited 6×
“Numerous studies, which have social defeat stress, predation stress, chronic social instability stress, administration of glucocorticoids, have reported marked interindividual variability in the response of an animal to stress that is suggestive of the presence of a susceptible AND resilient phenotype (Strekalova 1995…”
BackgroundMethodInfluentialBekris, S., Antoniou, K., Daskas, S., & Papadopoulou-Daifoti, Z. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.01.005 · Cited by 281
Papp, M., & Moryl, E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90516-9 · Cited by 272
Amygdala-Ventral Pallidum Pathway Decreases Dopamine Activity After Chronic Mild Stress in Rats
Chang, C.-H., & Grace, A. A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.020 · Cited by 239
Garza, J. C., Guo, M., Zhang, W., & Lu, X.-Y. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.161 · Cited by 209
Measuring behavior in mice with chronic stress depression paradigm
Strekalova, T., & Steinbusch, H. W. M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.12.014 · Cited by 207
Self-citationPharmacological validation of the chronic mild stress model of depression
Papp, M., Moryl, E., & Willner, P. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00697-4 · Cited by 205
Reliability of the chronic mild stress model of depression: A user survey
Willner, P. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.001 · Cited by 198
Couch, Y., Anthony, D. C., Dolgov, O., Revischin, A., Festoff, B., Santos, A. I., Steinbusch, H. W., & Strekalova, T. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.12.017 · Cited by 187 · cited 2×
“It was found that CMS procedures can mimic circadian rhythm disturbances that occur during depression as manifested by altered patterns of melatonin and corticosterone secretion, rectal temperature rhythmicity, and general activity (Gorka et al. 1996; Avery et al. 1999, Ushijima et al. 2006; Couch et al. 2013).”
BackgroundSelf-citationLarsen, M. H., Mikkelsen, J. D., Hay-Schmidt, A., & Sandi, C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.01.005 · Cited by 165
Update in the methodology of the chronic stress paradigm: internal control matters
Strekalova, T., Couch, Y., Kholod, N., Boyks, M., Malin, D., Leprince, P., & Steinbusch, H. M. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-9 · Cited by 163 · cited 11×
“…to addressing the mechanisms of the resilience to stress-induced depression, which, in resilient individuals, might involve circuits and pathways of the stress response that are distinct from those of susceptible individuals (Delgado et al. 2011; Strekalova et al. 2011; Palmfeldt et al. 2016).”
BackgroundMethodSelf-citationDepression-like phenotype following chronic CB1 receptor antagonism
Beyer, C. E., Dwyer, J. M., Piesla, M. J., Platt, B. J., Shen, R., Rahman, Z., Chan, K., Manners, M. T., Samad, T. A., Kennedy, J. D., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.020 · Cited by 160 · cited 2×
“2018) to 480 s (Chad et al. 2010) in stressed groups and from 5 s (Song et al.”
BackgroundLuo, D. D., An, S. C., & Zhang, X. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.05.010 · Cited by 155 · cited 1×
“Reduced body weight in the CMS-exposed group can be viewed as a possible marker of sufficient stress load that can lead to the induction of anhedonia in rodents (Vitale et al. 2009; Luo et al. 2008; Strekalova and Steinbusch 2010; Hu et al. 2017).”
BackgroundGreene, J., Banasr, M., Lee, B., Warner-Schmidt, J., & Duman, R. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.68 · Cited by 143
Karson, A., Demirtaş, T., Bayramgürler, D., Balcı, F., & Utkan, T. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12037 · Cited by 143
Bessa, J. M., Morais, M., Marques, F., Pinto, L., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.39 · Cited by 130 · cited 2×
“2010), deviant neuroanatomical features and interactions between the hippocampus and prefrontal cortex (Delgado et al. 2011; Bessa et al. 2013; Kafetzopoulos et al. 2018).”
BackgroundDelgado y Palacios, R., Campo, A., Henningsen, K., Verhoye, M., Poot, D., Dijkstra, J., Van Audekerke, J., Benveniste, H., Sijbers, J., Wiborg, O., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.014 · Cited by 113 · cited 8×
“…to addressing the mechanisms of the resilience to stress-induced depression, which, in resilient individuals, might involve circuits and pathways of the stress response that are distinct from those of susceptible individuals (Delgado et al. 2011; Strekalova et al. 2011; Palmfeldt et al. 2016).”
BackgroundMethodInfluentialBoulle, F., Massart, R., Stragier, E., Païzanis, E., Zaidan, L., Marday, S., Gabriel, C., Mocaer, E., Mongeau, R., & Lanfumey, L. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.125 · Cited by 91 · cited 2×
“…to the limited accuracy of behavioral tests, inter-individual variability of stress response, and the development of general hyperlocomotion that were previously described in murine CMS models (Strekalova et al. 2005; Schweizer et al. 2009; Boulle et al. 2014), which are discussed further below.”
BackgroundJayatissa, M. N., Henningsen, K., Nikolajsen, G., West, M. J., & Wiborg, O. (2010) · Stress · doi:10.3109/10253890902951786 · Cited by 69 · cited 5×
“…(Tang et al. 2019), reduced brain expression of BDNF, vascular endothelial factor, and other neuroplasticity markers (Bergström et al. 2007; Jayatissa et al. 2008, 2009, 2010; Taliaz et al. 2011; Sun et al. 2017), as well as increased expression of immediate early genes in the medial…”
BackgroundMethodResultInfluentialMcLaughlin, R. J., Hill, M. N., Dang, S. S., Wainwright, S. R., Galea, L. A. M., Hillard, C. J., & Gorzalka, B. B. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.053 · Cited by 65 · cited 2×
“2019), and glucocorticoid and cannabinoid receptors (McLaughlin et al. 2013; Sun et al. 2017).”
BackgroundChristiansen, S., Bouzinova, E. V., Palme, R., & Wiborg, O. (2012) · Stress · doi:10.3109/10253890.2011.654370 · Cited by 55 · cited 5×
“Christiansen et al. 2012 Wistar 9 >30% ↓ in sucrose comsumption from baseline No decrease (or even sometimes increase) in sucrose consumption from baseline.”
BackgroundInfluentialYu, Z., Chen, N., Hu, D., Chen, W., Yuan, Y., Meng, S., Zhang, W., Lu, L., Han, Y., & Shi, J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00004 · Cited by 52
What Is New about New Antidepressants?
Dubovsky, S. L. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000488945 · Cited by 37 · cited 2×
“Despite a variety of therapeutic regimens available for depression, many of them appear to be effective in only about a half of patients, and up to 35% of MDD cases remain refractory to treatment (Munos 2009; Pigott et al. 2010; Insel and Sahakian 2012; Moeler 2017; Dubovsky 2018; Safer and Zito 2019).”
BackgroundEconomic burden of relapse/recurrence in patients with major depressive disorder
Gauthier, G., Mucha, L., Shi, S., & Guerin, A. (2019) · Journal of Drug Assessment · doi:10.1080/21556660.2019.1612410 · Cited by 36 · cited 2×
“experience MDD over the course of a lifetime (Hasin et al. 2018; Gauthier et al. 2019).”
Background
Cited by
Pang, F., Yang, Y., Huang, S., Yang, Z., Zhu, Z., Liao, D., Guo, X., Zhou, M., Li, Y., & Tang, C. (2023) · Brain Sciences · doi:10.3390/brainsci13030436 · Cited by 25
Sundarakrishnan, A., & Clarke, P. B. S. (2022) · PLOS ONE · doi:10.1371/journal.pone.0276743 · Cited by 12
“3%) that is lower than the 1–2% concentration range commonly used in animal models of depression [46, 47].”
BackgroundInozemtseva, L. S., Yatsenko, K. A., Glazova, N. Y., Kamensky, A. A., Myasoedov, N. F., Levitskaya, N. G., Grivennikov, I. A., & Dolotov, O. V. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177068 · Cited by 5
Metadata
- Authors
- Strekalova, T., Liu, Y., Kiselev, D., Khairuddin, S., Chiu, J. L. Y., Lam, J., Chan, Y.-S., Pavlov, D., Proshin, A., Lesch, K.-P., Anthony, D. C., & Lim, L. W.
- Venue
- Psychopharmacology
- Published
- 2022-01-24
- Volume
- 239
- Issue
- 3
- Pages
- 663-693
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W4206939795
- Cited by
- 141
- References
- 57
- FWCI
- 14.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.